Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea

Previous studies have indicated that ramosetron, a 5-hydroxytryptamine-3 receptor antagonist, achieves global improvement in irritable bowel syndrome (IBS) symptoms in male patients with IBS with diarrhea (IBS-D). However, in addition to global assessment it was deemed important to assess "clin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BioPsychoSocial medicine 2017-03, Vol.11 (1), p.7-7, Article 7
Hauptverfasser:	Ida, Motoko, Nishida, Akito, Akiho, Hiraku, Nakashima, Yoshihiro, Matsueda, Kei, Fukudo, Shin
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Analysis Clinical trials Constipation Diarrhea Gastroenterology Health aspects Intestine Irritable bowel syndrome Medical technology Men Motility Pain Patients Quality of life Serotonin Serotonin receptor agonists Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!